← Eichor
Study identifier: NCT06981442 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Condition: Aedes-borne Diseases  ·  Sponsor: Institute of Tropical Medicine, Belgium

PhaseNA
Planned participants2050
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health. In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO). The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in the city of Kinshasa. In particular, a before-and-after interventional study will be piloted and tested in the health zone of Kinshasa, with the aim of providing preliminary evidence of the impact of vector control tools. Interventions will be implemented in 400 households for each arm for 12 months. Before, after and during the interventions, entomological surveys will be conducted in 160 households in each arm to define the density of the vectors. Mosquitoes will be tested for the possible presence of arbovirus RNA (dengue, chikungunya, Zika, yellow fever). During the pre-intervention per…

This description comes directly from the study's public registry record.

Talk to the study team

Luciana Lepore  ·  +32(0)32476666  ·  llepore@itg.be

Wim Van Bortel  ·  +32(0)32476666  ·  wvanbortel@itg.be

Always discuss trial participation with your own doctor first.

Locations (1)

Institut National de Recherche Biomédicale, INRBKinshasa, République Démocratique Du Congo, Democratic Republic of the CongoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06981442